Primary Immune Deficiency Treatment Consortium

@pidtc.bsky.social

The Primary Immune Deficiency Treatment Consortium (PIDTC) is part of the NIH's Rare Diseases Clinical Research Network and consists of 47 centers in North America with a centralized computerized registry with the aim to improve patient outcomes.

Meet our leadership! Rebecca Marsh, MD is the Clinical Director of the PID Program and HLH Center at Cincinnati Children’s Hospital. She was first author of the publication on improvement of CGD IBD following allogeneic transplant amongst other pivotal works as a member of the steering committee.

Bild

Meet our leadership! Christopher Dvorak, MD is the Chief of the Allergy, Immunology and BMT division and a Professor of Pediatric Hematology–Oncology at UCSF Benioff Children’s Hospital. As Co-Principal Investigator of the PIDTC, he plays a central role in coordinating multicenter research efforts.

Bild